ID26083A - 10-KAMFORSULFONATE PAROXOXINE FOR TREATMENT OF CNS INTERFERENCE - Google Patents
10-KAMFORSULFONATE PAROXOXINE FOR TREATMENT OF CNS INTERFERENCEInfo
- Publication number
- ID26083A ID26083A IDW20002168A ID20002168A ID26083A ID 26083 A ID26083 A ID 26083A ID W20002168 A IDW20002168 A ID W20002168A ID 20002168 A ID20002168 A ID 20002168A ID 26083 A ID26083 A ID 26083A
- Authority
- ID
- Indonesia
- Prior art keywords
- paroxoxine
- kamforsulfonate
- cns
- interference
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID26083A true ID26083A (en) | 2000-11-23 |
Family
ID=10831008
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20002169A ID26654A (en) | 1998-04-25 | 1999-04-23 | ASCORBATE PAROXCETINS |
| IDW20002168A ID26083A (en) | 1998-04-25 | 1999-04-23 | 10-KAMFORSULFONATE PAROXOXINE FOR TREATMENT OF CNS INTERFERENCE |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20002169A ID26654A (en) | 1998-04-25 | 1999-04-23 | ASCORBATE PAROXCETINS |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1089995A1 (en) |
| JP (1) | JP2002513019A (en) |
| KR (1) | KR20010042977A (en) |
| CN (1) | CN1297448A (en) |
| AP (1) | AP2000001963A0 (en) |
| AU (1) | AU3618499A (en) |
| BG (1) | BG104940A (en) |
| BR (1) | BR9909868A (en) |
| CA (1) | CA2330055A1 (en) |
| EA (1) | EA200001104A1 (en) |
| GB (1) | GB9808896D0 (en) |
| HU (1) | HUP0102116A3 (en) |
| ID (2) | ID26654A (en) |
| IL (1) | IL139081A0 (en) |
| NO (1) | NO20005352L (en) |
| PL (1) | PL343677A1 (en) |
| SK (1) | SK15912000A3 (en) |
| TR (1) | TR200003084T2 (en) |
| WO (1) | WO1999055698A1 (en) |
| ZA (1) | ZA200005912B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
| AU2003223158B2 (en) | 2002-01-09 | 2008-01-17 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| CN118267895A (en) * | 2018-10-30 | 2024-07-02 | 中国科学院化学研究所 | Method for preparing drug or drug intermediate amorphous material |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (en) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT. |
| US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
| ES2117557B1 (en) * | 1996-02-29 | 1999-07-01 | Ferrer Int | NEW PROCEDURE FOR OBTAINING (-) - TRANS -N-P-FLUOROBENZOILMETIL-4- (P-FLUOROFENIL) -3- ((3,4- (METHYLENDIOXI) PHENOXI) METHYL) -PIPERIDINE. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/en active Pending
- 1999-04-23 ID IDW20002169A patent/ID26654A/en unknown
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/en unknown
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 CN CN99805160A patent/CN1297448A/en active Pending
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/en unknown
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/en not_active Application Discontinuation
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/en not_active Application Discontinuation
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
- 1999-04-23 ID IDW20002168A patent/ID26083A/en unknown
- 1999-04-23 PL PL99343677A patent/PL343677A1/en not_active Application Discontinuation
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/en unknown
- 1999-04-23 EA EA200001104A patent/EA200001104A1/en unknown
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Application Discontinuation
- 1999-04-23 IL IL13908199A patent/IL139081A0/en unknown
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352L/en not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9808896D0 (en) | 1998-06-24 |
| JP2002513019A (en) | 2002-05-08 |
| TR200003084T2 (en) | 2001-02-21 |
| AP2000001963A0 (en) | 2000-12-31 |
| EA200001104A1 (en) | 2001-04-23 |
| EP1089995A1 (en) | 2001-04-11 |
| AU3618499A (en) | 1999-11-16 |
| HUP0102116A3 (en) | 2002-12-28 |
| HUP0102116A2 (en) | 2002-05-29 |
| NO20005352D0 (en) | 2000-10-24 |
| PL343677A1 (en) | 2001-08-27 |
| IL139081A0 (en) | 2001-11-25 |
| CA2330055A1 (en) | 1999-11-04 |
| WO1999055698A1 (en) | 1999-11-04 |
| BG104940A (en) | 2001-09-28 |
| ZA200005912B (en) | 2001-12-19 |
| NO20005352L (en) | 2000-10-24 |
| ID26654A (en) | 2001-01-25 |
| KR20010042977A (en) | 2001-05-25 |
| CN1297448A (en) | 2001-05-30 |
| SK15912000A3 (en) | 2001-04-09 |
| BR9909868A (en) | 2000-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012995D0 (en) | Compound useful for treating inflammatory diseases | |
| ID27092A (en) | MAKING OF ANHYDRIDAL FTALATES | |
| ID30062A (en) | SUBSTITUTIONAL BENZOPIRAN ANALOGUE FOR TREATMENT OF RADANG | |
| ID24638A (en) | COMPOUNDS OF ANTI ARYTHMIA BISPIDINA | |
| ID27191A (en) | METHODS FOR TREATMENT OF INSOMNIA | |
| NO20003065D0 (en) | Combination for effective treatment of impotence | |
| ID26990A (en) | METHOD OF MAKING DIMETHYLNAFTALENA | |
| ID25901A (en) | PROCESS OF MAKING 4-AMINOMETHYL-PYROLIDINE-3-ON PROTECTED | |
| ID27214A (en) | TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS | |
| ID17723A (en) | COMPOUND FOR TREATMENT | |
| IS4789A (en) | treatment Compounds | |
| ID28032A (en) | TRICICLIC OF PIPERIDIN-Δ3-AS ANTAGONIS-α2 | |
| ID26083A (en) | 10-KAMFORSULFONATE PAROXOXINE FOR TREATMENT OF CNS INTERFERENCE | |
| NO20003481D0 (en) | Procedure for the treatment of COPD | |
| ID24327A (en) | PRODUCTION OF AVERMEKTIN COMPOUNDS | |
| NO20012099D0 (en) | Process for the preparation of 4-arylpiperidine-3-carbinols and related compounds | |
| ID21920A (en) | 4-6-FLUORO- (1H) -INDOL-3-IL-1,2,3,6-TETRAH HYDROPIRINS SUBSTITUTED FOR TREATMENT OF CNS INTERFERENCE | |
| PT1175417E (en) | SUBSTITUTED COMPOUNDS OF BENZOLACTAMAS | |
| NO20006383L (en) | Process of treatment | |
| PT1088010E (en) | PRODUCTION OF POLYOLEFINS | |
| IL126681A0 (en) | Treatment of trauma-related conditions | |
| IL138843A0 (en) | Improved process for the manufacture of n- (1-cyanoalkyl) -2-phenoxypropionamide derivatives | |
| FI981803A0 (en) | Method for preventing the formation of precipitates | |
| NO20012301D0 (en) | New procedure for treatment | |
| NO20006382D0 (en) | Method of treating organophosphate poisoning |